Exome capture sequencing reveals new insights into hepatitis B virus-induced hepatocellular carcinoma at the early stage of tumorigenesis

Oncology Reports

Volumn 30, Issue 4, 2013, Pages 1906-1912

  Chen, Yong ^a,b   Wang, Lijuan ^a   Xu, Hexiang ^a   Liu, Xingxiang ^a   Zhao, Yingren ^b  

^a Huai'An Fourth People's Hospital   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Exome sequencing; Hepatitis B virus; Hepatocellular carcinoma; Somatic mutation

Indexed keywords

ADULT; ARTICLE; CNTN2 GENE; CONTROLLED STUDY; EXOME CAPTURE SEQUENCING; FLNA GENE; GENE; GENE MUTATION; GENE SEQUENCE; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PARP4 GENE; PRIORITY JOURNAL; SOMATIC MUTATION; VIRUS CARCINOGENESIS; WHOLE GENOME SEQUENCING; ZNF717 GENE;

CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; CONTACTIN 2; EXOME; FILAMINS; GENETIC VARIATION; GENOME; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; SEQUENCE ANALYSIS, DNA;

EID: 84882628975     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2652     Document Type: Article

References (29)

1. El-Serag HB and Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576, 2007.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
3. Perz JF, Armstrong GL, Farrington LA, Hutin YJ and Bell BP: The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45: 529-538, 2006.
4. Schütte K, Bornschein J and Malfertheiner P: Hepatocellular carcinoma - epidemiological trends and risk factors. Dig Dis 27: 80-92, 2009.
5. Stratton MR: Exploring the genomes of cancer cells: progress and promise. Science 331: 1553-1558, 2011.
6. Stratton MR, Campbell PJ and Futreal PA: The cancer genome. Nature 458: 719-724, 2009.
7. Meyerson M, Gabriel S and Getz G: Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 11: 685-696, 2010.
8. Sung WK, Zheng H, Li S, et al: Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet 44: 765-769, 2012.
9. Li M, Zhao H, Zhang X, et al: Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet 43: 828-829, 2011.
10. Tao Y, Ruan J, Yeh SH, et al: Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data. Proc Natl Acad Sci USA 108: 12042-12047, 2011.
11. Totoki Y, Tatsuno K, Yamamoto S, et al: High-resolution characterization of a hepatocellular carcinoma genome. Nat Genet 43: 464-469, 2011.
12. Li H and Durbin R: Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26: 589-595, 2010.
13. Li H, Handsaker B, Wysoker A, et al: The sequence alignment/map format and SAMtools. Bioinformatics 25: 2078-2079, 2009.
14. Koboldt DC, Zhang Q, Larson DE, et al: VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 22: 568-576, 2012.
15. Choi Y, Sims GE, Murphy S, Miller JR and Chan AP: Predicting the functional effect of amino acid substitutions and indels. PLoS One 7: e46688, 2012.
16. Ng PC and Henikoff S: SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31: 3812-3814, 2003.
17. Hussain SP, Schwank J, Staib F, Wang XW and Harris CC: TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene 26: 2166-2176, 2007.
18. Imbeaud S, Ladeiro Y and Zucman-Rossi J: Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma. Semin Liver Dis 30: 75-86, 2010.
19. Staib F, Hussain SP, Hofseth LJ, Wang XW and Harris CC: TP53 and liver carcinogenesis. Hum Mutat 21: 201-216, 2003.
20. Kew MC: Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis. Liver Int 23: 405-409, 2003.
21. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
22. Scorsone KA, Zhou YZ, Butel JS and Slagle BL: p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res 52: 1635-1638, 1992.
23. Bressac B, Kew M, Wands J and Ozturk M: Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350: 429-431, 1991.
24. Gouas DA, Shi H, Hautefeuille AH, et al: Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein. Carcinogenesis 31: 1475-1482, 2010.
25. Ladomery M and Dellaire G: Multifunctional zinc finger proteins in development and disease. Ann Hum Genet 66: 331-342, 2002.
26. Papavassiliou AG: Transcription factors: structure, function, and implication in malignant growth. Anticancer Res 15: 891-894, 1995.
27. Hans MA, Müller M, Meyer-Ficca M, Bürkle A and Küpper JH: Overexpression of dominant negative PARP interferes with tumor formation of HeLa cells in nude mice: evidence for increased tumor cell apoptosis in vivo. Oncogene 18: 7010-7015, 1999.
28. Ai J, Huang H, Lv X, et al: FLNA and PGK1 are two potential markers for progression in hepatocellular carcinoma. Cell Physiol Biochem 27: 207-216, 2011.
29. Scheel C, Onder T, Karnoub A and Weinberg RA: Adaptation versus selection: the origins of metastatic behavior. Cancer Res 67: 11476-11480, 2007.